Form 4: MetaVia Director Andrew Koven Receives Significant RSU Grant and Establishes Power of Attorney for SEC Filings

MetaVia Inc. Director and 10% Owner Andrew I. Koven was granted 28,147 restricted stock units, increasing his direct beneficial ownership to 45,699 shares, and formalized a Power of Attorney for regulatory compliance.

Summary

• Andrew I. Koven, a Director and 10% Owner of MetaVia Inc. (MTVA), received a grant of 28,147 Restricted Stock Units (RSUs) on June 30, 2025.
• This grant was made under MetaVia's Amended and Restated 2022 Equity Incentive Plan.
• The RSUs are scheduled to vest on the earlier of June 30, 2026, or the day immediately prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on Mr. Koven's continued service.
• Mr. Koven elected to defer the receipt of the shares upon vesting, in accordance with the Amended and Restated Non-Employee Director Compensation Policy, until the earlier of a change in control or his separation from service/death.
• Following this transaction, Mr. Koven's direct beneficial ownership of MetaVia common stock increased to 45,699 shares.
• Mr. Koven also executed a Power of Attorney on June 30, 2025, appointing Marshall Woodworth, Tony Wong, Phillip Torrence, Joshua Damm, or Stephanie Swan as attorneys-in-fact to manage his SEC filings and EDGAR account.

Sentiment

Score: 7

Explanation: The RSU grant to a director and 10% owner is a positive signal, aligning interests and indicating a structured compensation plan. The deferral of shares also suggests long-term commitment. The Power of Attorney is a routine administrative step. No negative information is present.

Positives

• Grant of 28,147 Restricted Stock Units (RSUs) to a director and 10% owner, Andrew I. Koven, aligns management's interests with long-term shareholder value.
• The grant is part of the company's Amended and Restated 2022 Equity Incentive Plan, indicating a structured approach to executive compensation and retention.
• The director's election to defer receipt of shares upon vesting suggests a long-term commitment to the company's future performance.
• The establishment of a Power of Attorney streamlines the director's regulatory compliance and SEC filing processes.

Risks

• The vesting of the 28,147 Restricted Stock Units is contingent upon Andrew I. Koven's continuing service to MetaVia Inc. until the applicable vesting date.

Future Outlook

The vesting schedule for the granted Restricted Stock Units extends to at least June 30, 2026, or the 2026 Annual Meeting, indicating a future commitment period for the director. The deferral election also points to a long-term perspective on share receipt.

Management Comments

• "Represents a grant of restricted stock units ('RSUs') issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests on the earlier of June 30, 2026 or the day immediately prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date."
• "In accordance with the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the 'Policy'), the Reporting Person elected to defer receipt of the shares of common stock upon the vesting of the RSUs until the earlier of the date that is (i) immediately prior to a Change in Control (as described in the Policy), or (ii) within 60 days following the Reporting Person's retirement or other separation from service with the Issuer or death, whichever is earlier."

Industry Context

This RSU grant is a standard practice in corporate compensation, particularly for directors, to align their interests with long-term shareholder value. It reflects a common mechanism used across various industries to incentivize retention and performance, especially in growth-oriented companies like MetaVia Inc. The Power of Attorney is a routine administrative measure for directors to facilitate timely SEC filings.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to directors is a common compensation practice, aligning with industry standards for executive and director incentives, similar to practices at technology or biotechnology companies.
• The vesting schedule tied to continued service and future dates (June 30, 2026, or 2026 Annual Meeting) is typical for such equity awards, comparable to those used by established companies to retain key talent.
• The deferral election, allowing the director to postpone receipt of shares until specific future events (change in control or separation), is a standard feature in many non-employee director compensation policies, providing tax planning flexibility and further aligning long-term interests, akin to policies at large public corporations.

Corporate Governance

Related Party Transactions

• Grant of 28,147 Restricted Stock Units (RSUs) to Andrew I. Koven, a Director and 10% Owner, under the company's Amended and Restated 2022 Equity Incentive Plan.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value, as the value of the RSUs is tied to the company's stock performance. It also represents a potential future dilution upon vesting, which is typical for equity compensation plans.
• Management/Employees: Reflects the company's commitment to using equity incentives for key personnel, potentially boosting morale and retention.

Next Steps

• Continued service of Andrew I. Koven with MetaVia Inc. until the vesting date.
• Vesting of 28,147 RSUs on the earlier of June 30, 2026, or the day immediately prior to the Issuer's 2026 Annual Meeting of Stockholders.
• Potential future receipt of shares by Andrew I. Koven upon a change in control or separation from service/death, as per his deferral election.

Key Dates

Keywords

MetaVia Inc., MTVA, Form 4, SEC filing, Restricted Stock Units, RSU grant, equity incentive plan, director compensation, insider transaction, beneficial ownership, Andrew I. Koven, Power of Attorney, corporate governance